Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer

Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEGFR) for mCRC for which second-line or higher standard chemotherapy has been ineffect...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Yefei, Zheng, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288029/
https://www.ncbi.nlm.nih.gov/pubmed/34290985
http://dx.doi.org/10.3389/fonc.2021.688231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288029/
https://www.ncbi.nlm.nih.gov/pubmed/34290985
http://dx.doi.org/10.3389/fonc.2021.688231

Ejemplares similares